BNGO News and Press, Bionano Genomics Inc. From 03/22/23

Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome is among several forms of Müllerian agenesis, a disorder impacting 1 in 4,500 females which is indicated by the absence or underdevelopment of the female reproductive system Researchers in the study hypothesized that a genome-wide structural...

2023-03-16 09:57:00 ET While it's true that the risks of an investment in an earlier-stage business are higher, there's sometimes a sweet spot where the largest portion of the risk burden is decreasing, but the market hasn't bid up the stock's price accordingly yet. Bionano Genomics ...

SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- Bionano Laboratories today announced the expansion of its clinical testing menu with the launch of two new laboratory developed tests (LDTs) based on optical genome mapping (OGM), OGM-Dx TM Postnatal Whole Genome SV and OGM-Dx TM Prenatal Whol...

Bionano CEO and president Dr. Erik Holmlin will participate with Dr. Bruce Korf, president of the ACMG Foundation, in the foundation’s educational and clinical laboratory genetics and genomics (LGG) awards ceremony by presenting the fellowship awards sponsored by Bionano A scientif...

2023-03-09 22:27:02 ET Bionano Genomics, Inc. (BNGO) Q4 2022 Earnings Conference Call March 9, 2023 16:30 ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive Officer Chris Stewart - Chief Financial Officer Conference Call ...

2023-03-09 21:30:29 ET Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO) Q4 2022 Earnings Call Mar 09, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Bionano Genomics (BNGO) Q4 2022 Earnings Call Trans...

2023-03-09 17:08:33 ET Bionano Genomics ( NASDAQ: BNGO ) set its 2023 revenue guidance range at between $35M and $38M, below the consensus of $39.63M. The company noted its outlook represents 26%-37% year-over-year growth. In Q4 2022, the genome analysis software solut...

Q4 revenue was $8.2 million, which represents a 30% increase over Q4 2021 2022 revenue was $27.8 million, which represents a 55% increase over year end 2021 Reached installed base of 240 Saphyr® systems as of YE 2022, which represents a 46% increase over YE 2021 Conference call...

2023-03-08 17:35:28 ET Major earnings expected after the bell on Thursday include: Oracle corporation ( ORCL ) DocuSign ( DOCU ) Wheaton Precious Metals Corp. ( WPM ) Bionano Genomics ( BNGO ) Ulta Beauty  (ULTA0) For further details see: ...

2023-03-07 09:45:00 ET Getting in on the ground level with a stock that's on track to grow massively is one of the better things you can do for your portfolio's health. No doubt, early-stage businesses are riskier and you could lose 100% of your money, but there's also the possibility of hu...